Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke
The DOI matches its Crossref record; 49 of the 53 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) has been associated with diabetes and cardiovascular disease; however, whether the relationship is causal is uncertain. We conducted a two-sample Mendelian randomization study to investigate the associations of PCOS with type 2 diabetes, coronary heart disease (CHD), and stroke. Association between PCOS and diabetes risk was examined in European and Asian cohorts, both sex specific and sex combined. Causal effects of PCOS on risks of CHD and stroke were evaluated in European cohorts. Stroke was analyzed as any stroke as well as four subtypes of stroke (ischemic, large artery, cardioembolic, small vessel). We found no association of genetically predicted PCOS with risk of diabetes, CHD, or stroke. This suggests that PCOS in and of itself does not increase the risk of these outcomes. Other features of PCOS (obesity, elevated testosterone, low sex hormone binding globulin) may explain the association between PCOS and cardiometabolic diseases. In light of these results, efforts to prevent cardiometabolic complications in PCOS should focus on women with high-risk features rather than all women with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity, insulin resistance, and dyslipidemia are common clinical features in women with PCOS and increase the risk for cardiometabolic diseases and reproductive cancers by ≥50% [3]”
From Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review (2025) · cites this paper as [3]
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 6×
“In all cases, the MR-Egger intercepts were not different from zero, indicating absence of directional pleiotropy.”
BackgroundMethodInfluentialBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“The weighted median approach can provide a consistent causal effect estimate as long as at least 50% of the information contributing to the analysis comes from valid instrumental variables (20).”
BackgroundMethodThe MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959 · cited 2×
“We used R 3.6.3 software and the R package TwoSampleMR (22) for the analyses.”
MethodInfluentialBurgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization
Bowden, J., Del Greco M, F., Minelli, C., Davey Smith, G., Sheehan, N., & Thompson, J. (2017) · Statistics in Medicine · doi:10.1002/sim.7221 · Cited by 1,887 · cited 1×
“Primary MR analyses were conducted with the inverse variance weighted (IVW) method with random effects (18).”
MethodMahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 1×
“However, some studies that did attempt to match for or statistically adjust for BMI reported positive association between PCOS and diabetes (25,31,32).”
ResultMalik, R., Chauhan, G., Traylor, M., Sargurupremraj, M., Okada, Y., Mishra, A., Rutten-Jacobs, L., Giese, A.-K., van der Laan, S. W., Gretarsdottir, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0058-3 · Cited by 1,599
Bowden, J., Del Greco M., F., Minelli, C., Davey Smith, G., Sheehan, N. A., & Thompson, J. R. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw220 · Cited by 1,565
Pulit, S. L., Stoneman, C., Morris, A. P., Wood, A. R., Glastonbury, C. A., Tyrrell, J., Yengo, L., Ferreira, T., Marouli, E., Ji, Y., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy327 · Cited by 1,163
Cited by
Items 101–200 of 244
Metabolic Syndrome in Polycystic Ovary Syndrome
Hsieh, Y.-C., Yang, P.-K., & Chen, M. (2021) · Fertility & Reproduction · doi:10.1142/s2661318221500158 · Cited by 4
Jiang, H., Guo, Y., Chen, L., Shi, H., Huang, N., Chi, H., Yang, R. J., Long, X., & Qiao, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113863 · Cited by 3
“I feel like it gets worse as I get older”: perspectives of peri-postmenopausal women with PCOS
Wright, P. J., Corbett, C. F., Dawson, R. M., & Burts, C. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1588505 · Cited by 4
Cardiometabolic risk in women with polycystic ovary syndrome: a comprehensive review
Cagnacci, A., ANTONELLI, G. A., VATTERONI, G., & Xholli, A. (2025) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.25.05732-x · Cited by 4
Wang, K.-Y., Yang, T., Ding, Y.-F., Zeng, A., Li, Y., & Qiang, J.-W. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1652954 · Cited by 3
“PCOS is also associated with long-term complications such as diabetes, cardiovascular diseases, and endometrial cancer (4).”
Onaolapo, O. J., Aworinde, O., Olufemi-Aworinde, K. J., & Onaolapo, O. J. (2026) · Acta Bioscientia Journal of Biomedical and Biological Science Research · doi:10.71181/actabioscientia12550 · Cited by 3
Vitamin D and Lipid Profiles in Infertile PCOS and Non-PCOS Females
Azhar, A., Alam, S. M., & Rehman, R. (2024) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2024.07.767 · Cited by 4
Bmal1 deficiency disrupts autophagy–apoptosis equilibrium in a hyperandrogenic PCOS-like rat model
Wu, Y., Huang, B., Yang, X., Zhang, Y., Lei, X., Li, M., & Ma, Y. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.104972 · Cited by 3
Можейко, Л. Ф. (2024) · Рецепт · doi:10.34883/pi.2024.27.2.006 · Cited by 3
The Importance of Hormonal Balance for Women's Health
Teleayo, A. (2023) · Journal of Community Health Provision · doi:10.55885/jchp.v3i3.307 · Cited by 2
“Dysregulation in these hormonal pathways can make contributions to situations like insulin resistance and metabolic syndrome, increasing the chance of kind 2 diabetes and cardiovascular disease in women (Zhu et al., 2021; Pylypchuk et al., 2021)).”
BackgroundMendelian randomization studies on ischemic stroke: a field synopsis and systematic review
Yang, J., Han, C., Zhang, Y., Tan, S., Wu, Q., Ma, Y., Duan, Y., Wang, Y., Wang, J., Liu, B., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06992-4 · Cited by 4
Qin, H., Liu, H., Sun, J., Cai, L., Tan, Y. Q., Li, M., Xiao, Y., & Li, L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332082 · Cited by 2
“The interplay between PCOS, obesity, type 2 diabetes, and cardiovascular disease is expected to exacerbate the overall disease burden, particularly in older age groups [34,35].”
Lv, X., & Lu, X. (2022) · BioMed Research International · doi:10.1155/2022/8099997 · Cited by 2
“According to statistics, more than 60% of CS patients have an underlying disease that includes T2DM [17].”
BackgroundRetractedUse of myo-inositol in the treatment of PCOS symptoms in adolescents
Pkhaladze, L., Unfer, V., & Dewailly, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91673-8.00001-7 · Cited by 3
Dadachanji, R., Khavale, S., Patil, A. D., & Mukherjee, S. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.01.023 · Cited by 2
Bai, X., Zheng, C., Yu, Y., Zhang, J., Cao, S., Hou, C., & Wang, S. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.101908 · Cited by 2
Lv, Y., & Luo, W.-J. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i22.5008 · Cited by 3
“Despite these advancements, the precise mechanisms underlying its cardioprotective effects warrant further elucidation[8,9].”
Areloegbe, S. E. J., Atuma, C. L., Aturamu, A., Ajadi, I. O., Adelekan, O. E., Ajadi, M. B., Akintayo, C. O., Omoruyi, G. O., Onyekweli, S. O., Anifowose, O. F., et al. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04157-5 · Cited by 2
Sun, Y., Wang, J., & Chen, G. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2504977 · Cited by 2
“This disorder not only affects women’s fertility, but is also associated with an increased risk of metabolic syndrome, type 2 diabetes, and cardiovascular disease [3].”
Tang, R., He, Q., Dai, M., & Zou, X. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.38.8.5523 · Cited by 2
Using Stem Cells to Treat Diabetes-Induced Infertility
Abedini, F., Giassi, F., Rahbarghazi, R., Hamidian, G., & Keyhanmanesh, . (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666221103143710 · Cited by 3
Hussein, K. S. (2022) · Research Square · doi:10.21203/rs.3.rs-2073766/v1 · Cited by 2
Hossain, R., Khan, R. N., Chowdhury, P. S. R., Huda, S. M. M. M., & Ahmed, N. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-93236-6_13 · Cited by 1
Gao, L. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03449-z · Cited by 1
Ali, B., Hadadi, I., Adam, M., Faqihi, W. A., Sayed, M., Alotaibi, S. A., Gareeballah, A., & England, A. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303396709250721152449 · Cited by 1
Areloegbe, S. E. J., Enye, A. L., & Olaniyi, K. S. (2025) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2025-0095 · Cited by 1
Zhang, H., Peng, L., & Yao, L. (2025) · Endokrynologia Polska · doi:10.5603/ep.104875 · Cited by 1
Dehghani, F., Arefnezhad, R., Tanideh, N., Karimi, F., Aliakbari, F., Mohseni, G., & Esmaeilpour, T. (2025) · Zygote · doi:10.1017/s0967199425100142 · Cited by 1
A multidisciplinary approach to polycystic ovary syndrome: synergy of methods
Andreeva, E. N., Mel'nichenko, G. A., Yarmolinskaya, M. I., Khamoshina, M. B., Сутурина, Л. В., Фархадовна, Б. Ф., Grigoryan, O. R., Sukhareva, O. Y., Tiselko, A. V., Vorotnikova, S. Y., et al. (2025) · Bulletin of Reproductive Health · doi:10.14341/brh12779 · Cited by 1
Salem, J. N., Vettese, R., Yamamoto, J. M., Koshy, S., Harrison, T. G., Stephenson, N., Ronksley, P. E., Metcalfe, A., Brennand, E. A., & Benham, J. L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-097971 · Cited by 1
Kheriji, N., Dallali, H., Gharbi, M., Krir, A., Bahlous, A. H. S., Ahmed, M. B., Mahjoub, F., Abid, A., Jamoussi, H., & Kéfi, R. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47121055 · Cited by 1
“Several studies have confirmed the association between PCOS, diabetes and its complications, such as cardiovascular disease [30].”
MASLD coexisting with PCOS increases cardiometabolic risk
Ayonrinde, O. T., Mori, T. A., Adams, L. A., Beilin, L. J., Olynyk, J. K., & Hart, R. J. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag008 · Cited by 2
From menarche to menopause: estrogenic influences on stroke-related depression in women
Tierney, L. K., Diaz, I. C., Patel, S. H., & Raval, A. P. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101232 · Cited by 1
Gong, Z., Li, D., Li, X., Tian, J., Guo, J., Zhao, Y., Lu, Y., Gao, S., & Li, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1753316 · Cited by 1
Recent Advances in the Genetics of Polycystic Ovary Syndrome
Jones, M. R., & Goodarzi, M. O. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_4 · Cited by 1
Self-citationA study on the factors affecting polycystic ovary syndrome in young women
Küçükakça, A. Ş., & GÜRBÜZ, T. (2023) · Journal of Controversies in Obstetrics & Gynecology and Pediatrics · doi:10.51271/jcogp-0021 · Cited by 1
王, 亚. (2024) · Medical Diagnosis · doi:10.12677/md.2024.141018 · Cited by 1
INFLAMMATORY STATUS IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME IN GAZA STRIP
Taha, M. (2022) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2022.239467
Wie hängen das polyzystische Ovarialsyndrom und Diabetes zusammen?
(2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1465-0515
Cardiovascular risk reduction in polycystic ovary syndrome
Shams, P., Ahmed, I., & Samad, Z. Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00027-x
A Life Course Approach to Diabetes
Papadimos, E., Morton, J. I., Harding, J. L., & Barr, E. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192864642.003.0006 · Cited by 1
Etiopatogenesis, Diagnostics and Treatment of Polycystic Ovarian Syndrome in Adolescents
Можейко, Л. Ф. (2023) · Репродуктивное здоровье Восточная Европа · doi:10.34883/pi.2023.13.4.001 · Cited by 1
Darenskaya, M. A., Belenkaia, L. V., Atalyan, A. V., Lazareva, L., Nadelyaeva, Y., Николаевна, Д. И., Sholokhov, L. F., Сутурина, Л. В., & Kolesnikova, L. I. (2024) · International Journal of Biomedicine · doi:10.21103/article14(1)_oa9
SÍNDROME DO OVÁRIO POLICÍSTICO: O QUE HÁ DE MAIS RECENTE NA LITERATURA
FRAGA, A. M. D., da Silva, A. S. M., MATTER, D. D. C., Pasini, I. S., KNOBLOCH, J. G., CARDORO, J. C., BARP, L. P., KOLLET, M. E. C., RASCH, O. R., SANTOS, P. H. C. D., et al. (2024) · doi:10.59290/978-65-6029-130-0.19
Men and Female Infertility: Multidisciplinary Review
Mr.Chethan Kumar, K. M., K.M, M. R. C. N., Srividya, M. R., Shantha, M. K. M., & Mrudula, K. (2024) · INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT · doi:10.55041/ijsrem36694
Contraception et syndrome des ovaires polykystiques
Chakhtoura, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-78270-1.00023-5
The effect of integrated medical care on the daily life of patients with coronary heart disease
Xiao, H., Deng, Y., Xiao, H., Liu, X., & Qin, N. (2024) · Medicine · doi:10.1097/md.0000000000040587
“[16] Moreover, community-specific nursing is essential for managing patients’ daily lives and is crucial for long-term maintenance.”
Scientific Progress in Polycystic Ovary Syndrome: Little by Little
Ott, J., & Hager, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14010200
“It was more likely that other features of PCOS, namely obesity, elevated testosterone, and low sex hormone binding globulin (SHBG) may explain the association between PCOS and cardiometabolic diseases [17].”
Zhu, S., Zhu, M., & Zhang, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-5978075/v1
Research Progress of Comorbidity of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis
张, 欣. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153652
Síndrome de ovario poliquístico y riesgo cardiovascular
Flores, G. C., Escobedo, R. D. L., Flores, R. S., Salcedo, T. C., & Pérez, B. G. (2025) · South Florida Journal of Development · doi:10.46932/sfjdv6n5-013
Wright, P. J., Corbett, C. F., & Wang, K. (2025) · Advances in Public Health · doi:10.1155/adph/3876104
“Clinical conditions associated with PCOS include obesity, insulin resistance, and dyslipidemia, increasing women ’ s risk of cardiometabolic diseases [3] and reproductive cancers [4].”
Metabolic complications in a large cohort of Portuguese women with hirsutism-related disorders
Pinto, J., Cera, N., & Pignatelli, D. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02744-9 · Cited by 1
Jiang, H., Chen, L., Huang, N., Shi, H., Chi, H., Yang, R., Long, X., & Qiao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26604178
Jiang, H., Chen, L., Huang, N., Shi, H., Chi, H., Yang, R., Long, X., & Qiao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26604175
Jiang, H., Chen, L., Huang, N., Shi, H., Chi, H., Yang, R., Long, X., & Qiao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26604181
Jiang, H., Chen, L., Huang, N., Shi, H., Chi, H., Yang, R., Long, X., & Qiao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26604169
Jiang, H., Chen, L., Huang, N., Shi, H., Chi, H., Yang, R., Long, X., & Qiao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26604172
Jiang, H., Si, M., Tian, T., Shi, H., Huang, N., Chi, H., Yang, R., Long, X., & Qiao, J. (2023) · Figshare · doi:10.6084/m9.figshare.23621302
Chen, S., Guo, Z., & Yu, Q. (2023) · Figshare · doi:10.6084/m9.figshare.24558172
Metadata
- Authors
- Zhu, T., Cui, J., & Goodarzi, M. O.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Goodarzi, Mark O.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-11-06
- Volume
- 70
- Issue
- 2
- Pages
- 627-637
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W3095084496
- Cited by
- 226
- References
- 53
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 36 · 2023: 83 · 2022: 29 · 2021: 13
- FWCI
- 27.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- polycystic ovary syndrome, type 2 diabetes, coronary artery disease, stroke, cardiometabolic disease, causal inference, genetic risk prediction, sex differences, stroke subtypes, obesity, testosterone, sex hormone-binding globulin
- MeSH terms
- Adult, Coronary Disease, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk, Comorbidity, Case-Control Studies, Stroke, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.